Canada: More Than A Pinky Promise: Recent Developments To The Promise Doctrine In Patent Law

Don't want your patent invalidated? Then you should diligently vet any promissory language in that patent because, as the following cases illustrate, such language raises significant risks of patent invalidation on the basis of inutility under the evolving and controversial promise doctrine in patent law.

BACKGROUND

On June 13, 2013, Eli Lilly and Company (Eli Lilly) initiated a C$500-million claim against the Government of Canada, alleging that Canada's patent laws violate the intellectual property standards set out in the North America Free Trade Agreement (NAFTA). While the action was spurred by the challenge to, and consequent invalidation of, two of Eli Lilly's pharmaceutical patents, the heart of the claim was aimed at use of the "promise doctrine" to invalidate patents in Canadian courts for lacking the level of utility promised in the patent specification. Specifically, Eli Lilly's notice of arbitration stated that "Canada's adoption of the promise doctrine was a watershed event in the development of Canada's intellectual property regime. Not only is Canada applying a utility test that violates the standard required under NAFTA, it is also applying the utility test in a way that discriminates against pharmaceuticals as a field of technology." While this NAFTA challenge is perhaps the most high-profile case involving the promise doctrine, the doctrine has also been the subject of significant academic debate, several decisions of the Federal Court and Federal Court of Appeal and has even drawn criticism from the United States Trade Representative.

PROMISE DOCTRINE ORIGIN 

The promise doctrine is often stated to have originated in Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., where the Supreme Court of Canada (SCC) defined inutility as meaning "that the invention will not work, either in the sense that it will not operate at all or, more broadly, that it will not do what the specification promises that it will do" [emphasis added]. In other words, if a patent makes a promise as to the utility of the invention, the patentee will be held to that promise, meaning that the patentee will be required to have demonstrated or soundly predicted that promised utility as of the filing date of its application. In contrast, if a patent makes no promises, then a "mere scintilla" of utility is sufficient to preserve its utility.

RECENT APPLICATIONS OF THE PROMISE DOCTRINE

Recent decisions have clarified two important aspects of the promise doctrine:

  1. A mere "goal" falls below the threshold of an enforceable promise
  2. An enforceable promise can be found outside of a patent's claims 

Not Every Goal is an Enforceable Promise

Recent decisions have clarified that a mere reference to the goals of a patent falls below the threshold of an express promise.

For example, in Pfizer Canada Inc. v. Apotex Inc., Justice S. Harrington of the Federal Court held that the patent at issue (for the drug Celebrex) contained only a goal of use as an anti-inflammatory agent in humans, not a promise of such. Justice Harrington reached this conclusion after considering multiple aspects of the patent which, in his view, weighed against the patent providing such an express promise, including: (1) that the patent only referred to treating a "subject", a term that does not necessarily imply use in humans; and (2) that the utility of the patent was demonstrated in tests using rats, suggesting that the patent only promised use in rats. Justice Harrington's rejection of a promise of use in humans in the Celebrex patent was upheld by the Federal Court of Appeal

Similarly, in AstraZeneca Canada Inc. v. Apotex Inc. (Apotex), Justice Rennie (now of the Federal Court of Appeal) affirmed and clarified the difference between patent goals and promises. Specifically, Justice Rennie clarified that promises are different from goals because promises are "explicit and define guaranteed or anticipated results of the patent [...] whereas goals merely relate to potential uses for the patent." With respect to the patent before him, Justice Rennie held that it promised compounds with an improved therapeutic profile because it stated that it "will" (not "may") provide such compounds. Justice Rennie's promise analysis was recently upheld by the Federal Court of Appeal

Promises Can Be Found Outside of a Patent's Claims 

Recent decisions have also held that a patent's promise may be found outside of its claims.

In Apotex, the promise identified by Justice Rennie was found outside of the patent's claims, though Justice Rennie's conclusion was reached after a consideration of the patent as a whole.  

Most recently, in Eli Lilly Canada Inc. v. Mylan Pharmaceuticals ULC, Justice de Montigny held that if a patent's claims "clearly and unequivocally" set out a promise, this should be taken as the promise of the patent. However, Justice de Montigny also clarified that if the promise is not clearly expressed in the patent's claims, a promise may be found outside of the claims, and that, in any event, the promise should be construed within the context of the patent as a whole. Indeed, despite his emphasis on the claims when construing a patent's promise, Justice de Montigny ultimately found a promise in the patent for the drug Cialis outside the claims and invalidated the patent for failing to demonstrate or soundly predict that promise. 

CONCLUSION

The promise doctrine has faced criticism for imposing a subjective utility standard that is arbitrary and unpredictable (see Norman Siebrasse, "The False Doctrine of False Promise," (2013) 29(1) Canadian Intellectual Property Review 3). Although some recent jurisprudence has reduced this uncertainty by establishing an analytical framework around the interpretation of patent promises (e.g. the delineation between goals and promises), much work remains to be done. 

The promise doctrine has also faced criticism for invalidating patents, on the basis of lack of utility, despite the fact that the inventions at issue actually had a high degree of utility. Others, in responding to this criticism, have argued, like Justice Rennie in Apotex, that constraining innovators from over-promising is a reasonable approach to preserving the core policy objectives of patent law "which serve to create consistency and clarity in the bargain struck between innovators and the public." 

The Federal Court of Appeal's decision in Apotex is the subject of an application for leave to appeal to the SCC. The SCC's guidance on the promise doctrine would bring some much-needed clarity to Canadian patent law. In the meantime, innovators should diligently vet any promissory language in their patents, whether or not that language is located in their patents' claims, because, as the foregoing cases illustrate, such language raises significant risks of patent invalidation on the basis of inutility.  

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
23 Nov 2018, Other, Toronto, Canada

Cybersecurity, including data privacy and security obligations, has become a critical chapter in every company’s risk management playbook.

28 Nov 2018, Speaking Engagement, Toronto, Canada

Arbitration has a number of advantages and some disadvantages for the resolution of domestic and international commercial disputes.

Similar Articles
Relevancy Powered by MondaqAI
Bereskin & Parr LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Bereskin & Parr LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions